Toolkit/selective CPAR inhibitors

selective CPAR inhibitors

Assay Method·Research·Since 2018

Also known as: compounds that selectively inhibit CPARs

Taxonomy: Technique Branch / Method. Workflows sit above the mechanism and technique branches rather than replacing them.

Summary

Many tools have been developed to interrogate particular aspects of AMPAR signaling, including compounds that selectively inhibit CPARs, raising exciting translational possibilities.

Usefulness & Problems

Why this is useful

These compounds are described as tools to interrogate particular aspects of AMPAR signaling by selectively inhibiting CPARs.; interrogating particular aspects of AMPAR signaling

Source:

These compounds are described as tools to interrogate particular aspects of AMPAR signaling by selectively inhibiting CPARs.

Source:

interrogating particular aspects of AMPAR signaling

Problem solved

They help isolate the contribution of CPAR-associated signaling and are presented as having translational potential.; providing selective pharmacological interrogation of CPAR-linked AMPAR signaling

Source:

They help isolate the contribution of CPAR-associated signaling and are presented as having translational potential.

Source:

providing selective pharmacological interrogation of CPAR-linked AMPAR signaling

Problem links

providing selective pharmacological interrogation of CPAR-linked AMPAR signaling

Literature

They help isolate the contribution of CPAR-associated signaling and are presented as having translational potential.

Source:

They help isolate the contribution of CPAR-associated signaling and are presented as having translational potential.

Taxonomy & Function

Primary hierarchy

Technique Branch

Method: A concrete measurement method used to characterize an engineered system.

Target processes

signalingtranslation

Implementation Constraints

cofactor dependency: cofactor requirement unknownencoding mode: genetically encodedimplementation constraint: context specific validationoperating role: sensor

Use requires access to compounds that selectively inhibit CPARs and an assay context in which AMPAR signaling can be measured.; requires pharmacological compounds that selectively inhibit CPARs

The abstract does not specify which CPAR inhibitor to use, how selective the compounds are in practice, or which alcohol-related adaptation they best resolve.; no specific compound names or performance details are provided in the abstract

Validation

Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication

Supporting Sources

Ranked Claims

Claim 1method applicationsupports2018Source 1needs review

Transgenic animals and optogenetics have been used to identify AMPAR adaptations in particular cell types and glutamatergic projections.

Claim 2tool usesupports2018Source 1needs review

Compounds that selectively inhibit CPARs have been developed as tools to interrogate AMPAR signaling and may have translational potential.

Approval Evidence

1 source1 linked approval claimfirst-pass slug selective-cpar-inhibitors
Many tools have been developed to interrogate particular aspects of AMPAR signaling, including compounds that selectively inhibit CPARs, raising exciting translational possibilities.

Source:

tool usesupports

Compounds that selectively inhibit CPARs have been developed as tools to interrogate AMPAR signaling and may have translational potential.

Source:

Comparisons

Source-stated alternatives

The abstract also mentions transgenic animals and optogenetics as other approaches used to identify AMPAR adaptations in specific cell types and projections.

Source:

The abstract also mentions transgenic animals and optogenetics as other approaches used to identify AMPAR adaptations in specific cell types and projections.

Source-backed strengths

described as selective for CPARs; noted to raise translational possibilities

Source:

described as selective for CPARs

Source:

noted to raise translational possibilities

The abstract also mentions transgenic animals and optogenetics as other approaches used to identify AMPAR adaptations in specific cell types and projections.

Shared frame: source-stated alternative in extracted literature

Strengths here: described as selective for CPARs; noted to raise translational possibilities.

Relative tradeoffs: no specific compound names or performance details are provided in the abstract.

Source:

The abstract also mentions transgenic animals and optogenetics as other approaches used to identify AMPAR adaptations in specific cell types and projections.

The abstract also mentions transgenic animals and optogenetics as other approaches used to identify AMPAR adaptations in specific cell types and projections.

Shared frame: source-stated alternative in extracted literature

Strengths here: described as selective for CPARs; noted to raise translational possibilities.

Relative tradeoffs: no specific compound names or performance details are provided in the abstract.

Source:

The abstract also mentions transgenic animals and optogenetics as other approaches used to identify AMPAR adaptations in specific cell types and projections.

Ranked Citations

  1. 1.
    StructuralSource 1Handbook of experimental pharmacology2018Claim 1Claim 2

    Seeded from load plan for claim cl4. Extracted from this source document.